For security purposes
FOR SECURITY PURPOSES - because Internet Explorer is no longer supported by Microsoft, we suggest that you interact with our secure site through one of our supported browsers - Google Chrome, Firefox, or MS Edge. If you continue to use this website with Internet Explorer you do so at your own risk and you may encounter problems.
Applications
Levetiracetam and Levetiracetam enantiomer Lux Amylose-1 USP System Suitability
23212
Separation Mode: Chiral
Chiral
Amylose-1
HPLC
Anticonvulsants
Pharmaceutical/Biopharmaceutical
Therapeutic / Clinical
Therapeutic / Clinical

Applications

Levetiracetam and Levetiracetam enantiomer Lux Amylose-1 USP System Suitability
Analytes
1levetiracetam enantiomer
2levetiracetam
Compound Name
Levetiracetam
CID
5284583
Molecular Formula
C8H14N2O2
Molecular Weight
170
No. Hydrogen Bond Acceptors
2
No. Hydrogen Bond Donors
1
Details
LC Conditions (App ID: 23212)
Column:
Brand Name:
Part No:
Phase Name:
Amylose-1
Elution Type:
Isocratic
Mobile Phase:
A: hexane
B: Ethanol
Gradient Profile:
Step No.Time(min)%A%B
108020
Flow Rate:
1 mL/min
Temperature:
25°C
Detection:
UV-Vis Abs.-Variable Wave.(UV) @ 215 nm (25°C)

Order Items Used in This Application

Similar Applications
search
No Data